vs
Side-by-side financial comparison of BALCHEM CORP (BCPC) and Forestar Group Inc. (FOR). Click either name above to swap in a different company.
Forestar Group Inc. is the larger business by last-quarter revenue ($273.0M vs $263.6M, roughly 1.0× BALCHEM CORP). BALCHEM CORP runs the higher net margin — 14.9% vs 5.6%, a 9.2% gap on every dollar of revenue. On growth, BALCHEM CORP posted the faster year-over-year revenue change (9.8% vs 9.0%). Over the past eight quarters, BALCHEM CORP's revenue compounded faster (4.9% CAGR vs -9.6%).
Balchem Corp is a global specialty chemicals and nutritional ingredients provider that develops, manufactures and distributes application-specific products for human nutrition, animal health, pharmaceutical and industrial end markets, serving customers across North America, Europe and Asia Pacific.
Forestar Group Inc. is a residential lot development company based in Arlington, Texas. The company has operations in 51 markets in 21 states and delivered 11,518 residential lots during the twelve-month period ended December 31, 2020. The company is publicly traded on the New York Stock Exchange and in October 2017 became a majority-owned subsidiary of D.R. Horton, Inc., the largest homebuilder by volume in the United States since 2002. The company primarily acquires entitled real estate and...
BCPC vs FOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $263.6M | $273.0M |
| Net Profit | $39.2M | $15.4M |
| Gross Margin | 35.6% | 20.1% |
| Operating Margin | 19.8% | 7.6% |
| Net Margin | 14.9% | 5.6% |
| Revenue YoY | 9.8% | 9.0% |
| Net Profit YoY | 16.8% | -6.7% |
| EPS (diluted) | $1.21 | $0.30 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $263.6M | $273.0M | ||
| Q3 25 | $267.6M | $670.5M | ||
| Q2 25 | $255.5M | $390.5M | ||
| Q1 25 | $250.5M | $351.0M | ||
| Q4 24 | $240.0M | $250.4M | ||
| Q3 24 | $239.9M | $551.3M | ||
| Q2 24 | $234.1M | $318.4M | ||
| Q1 24 | $239.7M | $333.8M |
| Q4 25 | $39.2M | $15.4M | ||
| Q3 25 | $40.3M | $86.9M | ||
| Q2 25 | $38.3M | $32.9M | ||
| Q1 25 | $37.1M | $31.6M | ||
| Q4 24 | $33.6M | $16.5M | ||
| Q3 24 | $33.8M | $81.5M | ||
| Q2 24 | $32.1M | $38.7M | ||
| Q1 24 | $29.0M | $45.0M |
| Q4 25 | 35.6% | 20.1% | ||
| Q3 25 | 35.7% | 22.3% | ||
| Q2 25 | 36.4% | 20.4% | ||
| Q1 25 | 35.2% | 22.6% | ||
| Q4 24 | 36.0% | 22.0% | ||
| Q3 24 | 35.6% | 23.9% | ||
| Q2 24 | 35.5% | 22.5% | ||
| Q1 24 | 34.0% | 24.9% |
| Q4 25 | 19.8% | 7.6% | ||
| Q3 25 | 20.4% | 16.9% | ||
| Q2 25 | 20.1% | 11.2% | ||
| Q1 25 | 20.4% | 11.6% | ||
| Q4 24 | 19.8% | 8.7% | ||
| Q3 24 | 20.0% | 19.7% | ||
| Q2 24 | 19.6% | 16.2% | ||
| Q1 24 | 17.4% | 17.6% |
| Q4 25 | 14.9% | 5.6% | ||
| Q3 25 | 15.1% | 13.0% | ||
| Q2 25 | 15.0% | 8.4% | ||
| Q1 25 | 14.8% | 9.0% | ||
| Q4 24 | 14.0% | 6.6% | ||
| Q3 24 | 14.1% | 14.8% | ||
| Q2 24 | 13.7% | 12.2% | ||
| Q1 24 | 12.1% | 13.5% |
| Q4 25 | $1.21 | $0.30 | ||
| Q3 25 | $1.24 | $1.70 | ||
| Q2 25 | $1.17 | $0.65 | ||
| Q1 25 | $1.13 | $0.62 | ||
| Q4 24 | $1.03 | $0.32 | ||
| Q3 24 | $1.03 | $1.59 | ||
| Q2 24 | $0.98 | $0.76 | ||
| Q1 24 | $0.89 | $0.89 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $74.6M | $211.7M |
| Total DebtLower is stronger | — | $793.2M |
| Stockholders' EquityBook value | $1.3B | $1.8B |
| Total Assets | $1.7B | $3.2B |
| Debt / EquityLower = less leverage | — | 0.44× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $211.7M | ||
| Q3 25 | $65.1M | $379.2M | ||
| Q2 25 | $65.4M | $189.2M | ||
| Q1 25 | $49.9M | $174.3M | ||
| Q4 24 | $49.5M | $132.0M | ||
| Q3 24 | $73.7M | $481.2M | ||
| Q2 24 | $63.7M | $359.2M | ||
| Q1 24 | $60.3M | $416.2M |
| Q4 25 | — | $793.2M | ||
| Q3 25 | — | $802.7M | ||
| Q2 25 | — | $872.8M | ||
| Q1 25 | — | $872.5M | ||
| Q4 24 | — | $806.8M | ||
| Q3 24 | — | $706.4M | ||
| Q2 24 | — | $706.1M | ||
| Q1 24 | — | $705.7M |
| Q4 25 | $1.3B | $1.8B | ||
| Q3 25 | $1.3B | $1.8B | ||
| Q2 25 | $1.3B | $1.7B | ||
| Q1 25 | $1.2B | $1.6B | ||
| Q4 24 | $1.1B | $1.6B | ||
| Q3 24 | $1.2B | $1.6B | ||
| Q2 24 | $1.1B | $1.5B | ||
| Q1 24 | $1.1B | $1.5B |
| Q4 25 | $1.7B | $3.2B | ||
| Q3 25 | $1.7B | $3.1B | ||
| Q2 25 | $1.7B | $3.1B | ||
| Q1 25 | $1.6B | $3.0B | ||
| Q4 24 | $1.6B | $3.0B | ||
| Q3 24 | $1.6B | $2.8B | ||
| Q2 24 | $1.6B | $2.7B | ||
| Q1 24 | $1.6B | $2.6B |
| Q4 25 | — | 0.44× | ||
| Q3 25 | — | 0.45× | ||
| Q2 25 | — | 0.52× | ||
| Q1 25 | — | 0.53× | ||
| Q4 24 | — | 0.50× | ||
| Q3 24 | — | 0.44× | ||
| Q2 24 | — | 0.47× | ||
| Q1 24 | — | 0.48× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $67.3M | $-157.0M |
| Free Cash FlowOCF − Capex | — | $-157.1M |
| FCF MarginFCF / Revenue | — | -57.5% |
| Capex IntensityCapex / Revenue | — | 0.0% |
| Cash ConversionOCF / Net Profit | 1.72× | -10.19× |
| TTM Free Cash FlowTrailing 4 quarters | — | $93.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $67.3M | $-157.0M | ||
| Q3 25 | $65.6M | $256.3M | ||
| Q2 25 | $47.3M | $15.8M | ||
| Q1 25 | $36.5M | $-19.8M | ||
| Q4 24 | $52.3M | $-450.0M | ||
| Q3 24 | $51.3M | $119.2M | ||
| Q2 24 | $45.0M | $-61.7M | ||
| Q1 24 | $33.4M | $-59.2M |
| Q4 25 | — | $-157.1M | ||
| Q3 25 | — | $255.6M | ||
| Q2 25 | — | $15.0M | ||
| Q1 25 | — | $-20.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $118.4M | ||
| Q2 24 | — | $-62.3M | ||
| Q1 24 | — | $-59.8M |
| Q4 25 | — | -57.5% | ||
| Q3 25 | — | 38.1% | ||
| Q2 25 | — | 3.8% | ||
| Q1 25 | — | -5.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 21.5% | ||
| Q2 24 | — | -19.6% | ||
| Q1 24 | — | -17.9% |
| Q4 25 | — | 0.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.0% | ||
| Q3 24 | — | 0.1% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.2% |
| Q4 25 | 1.72× | -10.19× | ||
| Q3 25 | 1.63× | 2.95× | ||
| Q2 25 | 1.23× | 0.48× | ||
| Q1 25 | 0.98× | -0.63× | ||
| Q4 24 | 1.56× | -27.27× | ||
| Q3 24 | 1.52× | 1.46× | ||
| Q2 24 | 1.40× | -1.59× | ||
| Q1 24 | 1.15× | -1.32× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
FOR
| D.R.Horton Inc. | $183.8M | 67% |
| Other | $89.2M | 33% |
